Related Experiment Videos
Principles of nephrectomy for malignant disease
1Department of Urology, Erasmus University and Academic Hospital, Rotterdam, The Netherlands. mickisch@urol.azr.nl
BJU International
|April 4, 2002
Summary
Radical nephrectomy for renal cell carcinoma (RCC) traditionally used a transperitoneal approach. Newer evidence suggests an extraperitoneal approach may offer similar cancer control with less patient morbidity.
Area of Science:
- Uro-oncology
- Surgical Oncology
- Nephrology
Background:
- The transperitoneal approach was historically favored for radical nephrectomy in renal cell carcinoma (RCC) to control renal vessels early.
- This approach aimed to minimize tumor cell dissemination during surgery, based on retrospective data.
- However, recent evidence suggests potential benefits of the extraperitoneal (translumbar) approach for RCC, including reduced morbidity.
Purpose of the Study:
- To evaluate the oncological efficacy and morbidity of different surgical approaches for renal cell carcinoma (RCC).
- To address the limitations of retrospective data and the need for robust evidence regarding surgical techniques in RCC management.
- To explore advancements in systemic therapy and combined treatments for advanced-stage RCC.
Main Methods:
- Review of existing retrospective data comparing transperitoneal and extraperitoneal approaches for radical nephrectomy.
- Analysis of oncological outcomes and patient morbidity associated with each surgical technique.
- Discussion of the need for large, randomized multicenter trials to confirm findings.
Main Results:
- The transperitoneal approach was the historical standard for RCC surgery.
- The extraperitoneal approach may offer comparable oncological efficacy with reduced morbidity.
- Current evidence is largely retrospective or statistically insignificant, precluding firm conclusions.
Conclusions:
- Further large-scale randomized trials are necessary to definitively compare surgical approaches for RCC.
- Improvements in RCC survival may depend on systemic therapies and combined treatment strategies.
- Surgical intervention remains crucial, especially with the rise of immunotherapeutic strategies in uro-oncology.